#174: Vaping and the FDA - podcast episode cover

#174: Vaping and the FDA

May 12, 201734 minEp. 173
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

How does an e-vapor business navigate the FDA’s approval process? On August 8, 2016, the Food and Drug Administration’s “Deeming Rule” took effect, starting a two-year period where every manufacturer of e-cigarettes, e-liquid, and other vapor products would have to get permission from the FDA to keep their products on the market. You’ve heard some statistics on this podcast trying to quantify the regulatory burden, which could be anywhere from a few hundred thousand to millions of dollars per product. But what does that actually look like in the real world? Chris Howard and Jeff Sanderson from E-Alternative Solutions discuss the impact and what they’re doing to get their Cue product through the FDA’s process.

For the best experience, listen in Metacast app for iOS or Android